Skin care trends
This article was originally published in The Rose Sheet
Traditional skin care marketers are attempting to compete with dermatologist-developed skin care brands such as Dr. Perricone and Dr. Brandt by offering products with therapeutic, high-end positioning, market research firm Kline & Co. concludes in skin care study to be published this fall. Products pursuing that approach include Avon Clinical and P&G's Olay Regenerist, which are touted as advanced anti-aging offerings. Prestige marketers such as Estee Lauder also are offering more clinically-positioned skin care treatments. Lauder recently purchased dermatologist-developed Rodan & Field's skin care line, while firm's Prescriptives brand relies on spokesperson Dr. Karen Grossman to promote its Dermapolish at-home microdermabrasion system (1"The Rose Sheet" July 21, 2003, p. 9)...
You may also be interested in...
Estee Lauder is moving into the dermatological skin care category with the acquisition of Rodan & Fields, a product line developed by dermatologists and sold in selective high-end department stores
Based on top-line Phase III data for garadacimab, CSL is preparing to submit the Factor XIIa inhibitor for US FDA approval for monthly prophylaxis of hereditary angioedema and expand the firm’s HAE franchise.
FDA says warning to VPR Brands could be its first move to reign in sales of nicotine gummies. Statements on brand’s site could indicate sales of nicotine gummies for smoking cessation are on the rise even though the claim isn’t approved.